HYPERTROPHIC OSTEOARTHROPATHY

This adverse event was reported 68 times

HYPERTROPHIC OSTEOARTHROPATHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 RILONACEPT 1 0.0009
1 VORICONAZOLE 21 0.0007
2 DALTEPARIN SODIUM 5 0.0005
3 AMIFAMPRIDINE PHOSPHATE 1 0.0003
4 TOPOTECAN 2 0.0003
5 COLCHICINE 7 0.0003
6 CRIZOTINIB 3 0.0002
7 OCTREOTIDE ACETATE 7 0.0002
8 AMOXICILLIN AND CLAVULANATE POTASSIUM 1 0.0002
9 CANAKINUMAB 2 0.0002
See all drugs enriched for association with HYPERTROPHIC OSTEOARTHROPATHY